
Moderna shares fell after the FDA refused to review the new flu vaccine
Source link

Moderna shares fell after the FDA refused to review the new flu vaccine
Source link
Barratt Redrow shares fell as profit margins contracted despite volume growth Source link
The European market was mixed as investors read the flurry of earnings Source link